CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis
BackgroundCFTR modulators decrease some etiologies of CF airway inflammation; however, data indicate that non-resolving airway infection and inflammation persist in individuals with CF and chronic bacterial infections. Thus, identification of therapies that diminish airway inflammation without allow...
Saved in:
Main Authors: | Katherine B. Hisert (Author), Timothy P. Birkland (Author), Kelly Q. Schoenfelt (Author), Matthew E. Long (Author), Brenda Grogan (Author), Suzanne Carter (Author), W. Conrad Liles (Author), Edward F. McKone (Author), Lev Becker (Author), Anne M. Manicone (Author), Sina A. Gharib (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inflammation and CFTR: Might Neutrophils be the Key in Cystic Fibrosis?
by: V. Witko-Sarsat, et al.
Published: (1999) -
CFTR and Ca2+ signaling in cystic fibrosis
by: Fabrice eAntigny, et al.
Published: (2011) -
Strategies to circumvent the CFTR defect in cystic fibrosis
by: Frederic eBecq, et al.
Published: (2013) -
Nutritional impact of CFTR modulators in children with cystic fibrosis
by: Margaux Gaschignard, et al.
Published: (2023) -
Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass
by: Marialena Mouzaki, et al.
Published: (2023)